Modafinil Patent Expiration
Modafinil is Used for treating excessive daytime sleepiness associated with narcolepsy. It was first introduced by Nuvo Pharmaceuticals (Ireland) Dac
Modafinil Patents
Given below is the list of patents protecting Modafinil, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Provigil |
US7297346 (Pediatric) | Pharmaceutical formulations of modafinil |
May 29, 2024
(Expired) | Nuvo Pharms |
| Provigil | US7297346 | Pharmaceutical formulations of modafinil |
Nov 29, 2023
(Expired) | Nuvo Pharms |
| Provigil |
USRE37516 (Pediatric) | Acetamide derivative having defined particle size |
Apr 06, 2015
(Expired) | Nuvo Pharms |
| Provigil | USRE37516 | Acetamide derivative having defined particle size |
Oct 06, 2014
(Expired) | Nuvo Pharms |
Modafinil's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List